RCTs are the gold standard in drug research, but rising placebo (PBO) response rates with global recruitment could disto
Tweet Content
RCTs are the gold standard in drug research, but rising placebo (PBO) response rates with global recruitment could distort treatment effects. Limited access to care in less affluent countries may be a factor.
#ACR24 @RheumNow ABST#1746 https://t.co/fVeNcw5qwO
Show on Archive Page
On
Display in Search Results
On
PDQ
Off